Description: Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody which is in Phase 1 clinical trials for use in the treatment of thyroid eye disease. In addition, the company's develops SLRN-517, a fully human IgG1 monoclonal antibody targeting c-KIT, which is in preclinical stage for use in the treatment of chronic urticaria. Acelyrin, Inc. was incorporated in 2020 and is headquartered in Agoura Hills, California.
Home Page: www.acelyrin.com
4149 Liberty Canyon Road
Agoura Hills,
CA
91301
United States
Phone:
805-730-0360
Officers
| Name | Title |
|---|---|
| Ms. Mina Kim J.D. | CEO & Director |
| Mr. Gilbert M. Labrucherie J.D. | CFO & Chief Business Officer |
| Mr. Tyler Marciniak | Head of Investor Relations & Communications |
| Mr. K. Amar Murugan J.D. | Chief Legal Officer |
| Ms. Kelly Chow | Chief People Officer |
| Ms. Suzy Buckhalter CPA | Senior Director of Finance & Accounting |
| Mr. Kenneth A. Lock | Chief Commercial Officer |
| Dr. Shephard Mpofu M.D. | Chief Medical Officer |
| Ms. Patricia A. Turney | Chief Technical Operations Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.6723 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2023-05-04 |
| Fiscal Year End: | December |
| Full Time Employees: | 135 |